Publications
-
Prada-Varela E, Táboas-Outón P, Andrades E, Gomez-Gonzalez S, Mateo-Lozano S, Cebrià A, Berenguer-Molins P, Perera-Bel J, Arcon JP, Saen-Oon S, Díaz L, Gay M, Folch-I-Casanovas I, Odena A, Vilaseca M, Rovira Q, García-Gerique L, Rodriguez E, Rovira-Zurriaga C, Rodrigues G, Carcaboso AM, Avgustinova A, Hernandez-Muñoz MI and Mora J.
PRKG1 hinders myogenic differentiation and predicts response to AKT inhibitor ipatasertib in Rhabdomyosarcoma.
Nature Communications . 16(1): 9816-9816.
-
Sentís I, Melero JL, Cebrià A, Grzelak M, Soto M, Michel A, Rovira Q, Rodriguez-Hernandez CJ, Caratù G, Urpi A, Sauvage C, Mendizabal-Sasieta A, Maspero D, Lavarino C, Pascual-Reguant A, Castañeda-Heredia A, Muñoz Perez JP, Mora J, Harari A, Nieto JC, Avgustinova A and Heyn H.
Spatiotemporal T-cell tracking for personalized T-cell receptor T-cell therapy designs in childhood cancer.
ANNALS OF ONCOLOGY . 36(9): 1096-1106.
-
Bosch-Calvet, M, Perez-Venteo, A, Cebrià A, Garcia-Cajide, M and Mauvezin, C.
Nuclear stiffness through lamin A/C overexpression differentially modulates chromosomal instability biomarkers.
BIOLOGY OF THE CELL . 117(2): 12001-12001. Number of citations: 5
